Sarah Rumple Mahan
Editor-In-Chief
Sarah Rumple Mahan is an award-winning veterinary writer and editor living in Denver, Colorado. Sarah has written for Today’s Veterinary Business since 2018, and she became the publication’s editor-in-chief in 2026. Reach her at smahan@navc.com.

Covetrus has issued a public statement responding to the Federal Trade Commission’s (FTC) lawsuit seeking to block its proposed merger with MWI Animal Health.
According to the statement, Covetrus intends to defend the transaction in court, arguing that the merger will improve clinic economics and lower the cost of service. The distributor claims the FTC’s antitrust case relies on a “narrow and outdated view” of the veterinary supply chain, noting that clinics routinely utilize multiple purchasing channels to maintain competitive pricing.
To illustrate market dynamics, Covetrus’ statement highlighted several alternative purchasing avenues:
- Direct manufacturer sales: The company noted that nearly all veterinary practices currently purchase products directly from manufacturers, some of which maintain larger sales teams than the distributors themselves.
- Online marketplaces: More than 60% of U.S. practices utilize online platforms to compare prices, earn rebates, and order from over 40 different distributors.
- Retail disintermediation: Retailers are increasingly selling parasiticides, pharmaceuticals, and therapeutic diets directly to pet owners, bypassing traditional distributors and veterinary clinics.
The company stated that competition from these sources has “consistently pushed prices down for clinics,” a reality it claims will remain unaffected by the proposed merger.
